Ф. Ф. Муфазалов

ORCID: 0000-0003-3450-2642
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Treatment and Pharmacology
  • Head and Neck Cancer Studies
  • Intestinal and Peritoneal Adhesions
  • Lung Cancer Treatments and Mutations
  • Appendicitis Diagnosis and Management
  • Radiopharmaceutical Chemistry and Applications
  • Thyroid Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Mechanisms and Therapy
  • Lung Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Chemical Reactions and Isotopes
  • Advanced Breast Cancer Therapies
  • Hernia repair and management
  • Vascular Malformations Diagnosis and Treatment
  • Cleft Lip and Palate Research
  • Effects of Radiation Exposure
  • Cerebral Venous Sinus Thrombosis
  • Cancer Research and Treatment
  • Genetically Modified Organisms Research
  • Estrogen and related hormone effects
  • Brain Metastases and Treatment
  • Medical Imaging and Analysis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Management of metastatic bone disease

Republican Oncological Clinical Dispensary
2002-2023

Bashkir State Medical University
2017-2022

Ministry of Health
2020

Ministry of Health of the Russian Federation
2019

Ezra E.W. Cohen Denis Soulières Christophe Le Tourneau José Dinis Lisa Licitra and 95 more Myung‐Ju Ahn Ainara Soria Jean‐Pascal Machiels Nicolas Mach Ranee Mehra Barbara Burtness Pingye Zhang Jonathan D. Cheng Ramona F. Swaby Kevin J. Harrington Mirelis Acosta-Rivera Douglas R. Adkins Morteza Aghmesheh Myung‐Ju Ahn Mario Airoldi Eduardas Aleknavičius Yousuf Al-Farhat Alain P. Algazi Salah Almokadem Anna Alyasova Jessica R. Bauman Marco Benasso Alfonso Berrocal Victoria Bray Barbara Burtness Francesco Caponigro Ana Castro Terrence P. Cescon Kelvin Chan Arvind Chaudhry Bruno Chauffert Ezra E.W. Cohen Tibor Csöszi Jan Paul de Boer Jean‐Pierre Delord Andreas Dietz José Dinis Charlotte Dupuis Laurence Digue József Erfán Yolanda Escobar Mererid Evans Mary J. Fidler Martin Förster Signe Friesland Apar Kishor Ganti Lionnel Geoffrois Clíona Grant Viktor Gruenwald Kevin J. Harrington Thomas K. Hoffmann Geza Horvai Arturas Inčiūra Raymond Woo-Jun Jang Petra Jankowska Antonio Jimeno Mano Joseph Alejandro Juárez Ramiro Bogusława Karaszewska Andrzej Kawecki Ulrich Keilholz Ulrich Keller Sung‐Bae Kim Judit Kocsis Nuria Kotecki Mark Kozloff J. Lambea László Landherr Yuri Lantsukhay Sergey Lazarev Lip Way Lee Christophe Le Tourneau Lisa Licitra Igor Lifirenko Nicolas Mach Danko Martincic О. В. Маторин Margaret McGrath Jean‐Pascal Machiels Ranee Mehra Krzysztof Misiukiewicz John C. Morris Ф. Ф. Муфазалов Jiaxin Niu Devraj Srinivasan Pedro Pérez Segura Daniel Rauch Maria Leonor Ribeiro Cristina P. Rodriguez Frédéric Rolland Antonio Russo Ágnes Ruzsa Frederico Sanches Sangwon Shin Mikhail Shtiveland

10.1016/s0140-6736(18)31999-8 article EN The Lancet 2018-11-30

Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these patients. study objective to analyze experience lenvatinib RR-DTC the Russian Federation. Materials and methods. data from 18 sites Russia was analyzed period December 2015 September 2019. Seventyseven histologically verified DTC, proven...

10.17650/2222-1468-2020-10-1-65-72 article EN cc-by Head and neck tumors (HNT) 2020-04-11

Adhesive intestinal obstruction is one of the most common and potentially fatal complications after abdominal surgery. Among gynecological operations, leading to development adhesive obstruction, hysterectomy cause emergency intervention. At same time, in recent past, mortality was observed from 40% 60%. Currently ,due endovideosurgery, it possible reduce postoperative rate however, remains between 10% 20% all patients with small bowel obstruction. The cornerstone improvement treatment...

10.24835/1607-0763-2019-2-119-126 article EN cc-by Medical Visualization 2019-07-16

Thyroid cancer is one of the most widespreaded malignant endocrine tumors. Morbidity constantly increasing in world and Russian Federation during last decade [1, 2]. So, United States marked annual increase diagnosed cases thyroid by 6.4% with mortality 0.9% [3]. In 5.4% 2003–2013. 2013 9624 new morbidity 93.2 on 100 000 citizens [1]. Differentiated more than 90% all [4].

10.18027/2224-5057-2015-3-24-33 article EN cc-by Malignant tumours 2015-10-26

In the paper there is presented a review of foreign and literature data, documented in electronic search system PubMed regarding epidemiology, early prenosological diagnosis, carcinogenic factors for development malignant respiratory neoplasms, lung cancer.

10.17816/pmj35593-97 article EN Perm Medical Journal 2018-12-12

In 2017 the first published PFS results of PACIFIC study demonstrated new opportunities immunotherapy in locally-advanced unresectable non-small-cell lung cancer (NSCLC) after chemoradiation (CRT). The positive overall survival this trial were received next year. This has become more then 10 years failure all trials which investigated different approaches for improvement efficacy standard CRT (induction therapy, consolidation target increased RT dose). opened to improve outcomes patient’s...

10.26442/18151434.2019.3.190679 article EN cc-by-nc Journal of Modern Oncology 2019-09-15

The most important problem determining the indications for surgical treatment of peritoneal adhesion is associated with uncertainty criteria early diagnosis intestinal obstruction. Of all common acute diseases abdominal cavity, obstruction gives highest lethality. main reason this untimely diagnosis. In two groups patients, we performed a study chronic disease using X-ray computed tomography (RCT), (58 patients) and absence pathology (56 patients). Analyzing nonparametric statistics...

10.47093/22187332.2018.4.55-59 article EN cc-by Sechenov Medical Journal 2018-12-30

Introduction . Unresectable oral cancer is an urgent and complex problem in modern oncology. Annually, the proportion of patients with stage III–IV 35 %, one-year mortality rate for this pathology reaches 32 %. Patients advanced tumors usually have a negative prognosis treatment tactics are limited to radiation therapy (RT), chemoradiation therapy, or sequential including induction chemotherapy (CT). Polymodal particular interest area. The study objective – analyze results treatment, CT...

10.17650/2222-1468-2021-11-4-41-49 article EN cc-by Head and neck tumors (HNT) 2022-02-13

Breast cancer (BC) is a heterogeneous disease characterized by the presence or absence of membrane receptor overexpression on tumor cells that correlates with prognosis. Understanding patterns and mechanisms progression gained through clinical experience managing BC patients important. The treatment strategy depends hormone status tumor, HER2 / neu expression, proliferative activity level. A case advanced luminal breast reported, rationale for sequential provided taking into account...

10.18027/2224-5057-2020-10-3 article EN cc-by Malignant tumours 2021-07-07

The article presents a review of clinical trials treatment the triple negative breast cancer (TNBC). It considered activity existing target agents and chemotherapy. Described is not an ordinary case course TNBC.

10.18027/2224-5057-2014-1-19-31 article EN cc-by Malignant tumours 2015-05-19

Introduction. Th e growing incidence of oropharyngeal cancer is driven by an increase in frequency HPV-associated cancer. morbidity pattern area-specific. Aim. To analyze the diagnosis and treatment Republic Bashkortostan for 2020. Materials methods. authors carried out a 2020 retrospective analysis results patients with 79 were identified this diagnosis. 84.8% (67/79) among them males 15.2% females (12/79). mean age was 59.1 years. site primary tumor on oropharynx lateral wall 37.8% cases...

10.24060/2076-3093-2022-12-4-267-274 article EN cc-by Creative Surgery and Oncology 2023-01-02
Coming Soon ...